What type of study is this?

September 27, 2025Cancer Research

Abstract A003: The clinical impact of targeted next-generation sequencing for advanced pediatric and AYA sarcoma patients in the iCat2/GAIN Consortium Study

View Full Paper

Ask AI

Bookmark

Authors

Observational study finds genomic alterations in sarcoma patients with implications for treatment decisions.

Identifying genomic alterations through next generation sequencing revealed diagnostic and prognostic variants in 84% of patients.
In total, 425 sarcoma patients had at least one variant with therapeutic relevance identified through NGS testing.
Only 6% of patients received matched targeted therapy, resulting in a low response rate of 10% among those treated.
These findings highlight how next generation sequencing can inform treatment strategies for advanced sarcomas in young patients.

Comeau et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark